What is Grove Labs?
Headquartered in Somerville, Massachusetts, Grove Labs operates at the intersection of advanced medical diagnostics and imaging technology. With a dedicated workforce of 20 to 49 professionals, the organization has established a robust market presence, generating annual revenues between 5M and 10M. The company specializes in providing high-precision laboratory services, catering to the increasing demand for accurate, data-driven clinical insights. By maintaining a lean yet highly skilled team, Grove Labs effectively balances operational agility with the rigorous quality standards required in the modern healthcare sector, ensuring that its diagnostic outputs remain at the forefront of clinical excellence.
How much funding has Grove Labs raised?
Grove Labs has raised a total of $4M across 2 funding rounds:
Angel/Seed
$2.2M
Private Equity
$1.8M
Angel/Seed (2014): $2.2M with participation from Felicis Ventures and Upfront Ventures
Private Equity (2015): $1.8M, investors not publicly disclosed
Key Investors in Grove Labs
Felicis Ventures
A Menlo Park-based venture capital firm that raises multistage funds to invest in early and growth-stage technology companies across sectors such as SaaS, AI, and fintech.
Upfront Ventures
A Los Angeles-based venture capital firm focusing on technology businesses, including digital media, SaaS, and retail innovation, providing capital for growth and scaling.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Grove Labs?
With the recent influx of capital, Grove Labs is well-positioned to transition from its current operational phase into a period of accelerated enterprise-level expansion. The strategic roadmap likely involves enhancing its imaging capabilities and potentially broadening its service portfolio to capture a larger share of the regional diagnostic market. As the firm matures, the focus will shift toward optimizing laboratory throughput and integrating next-generation imaging technologies to maintain its competitive edge. Investors and industry stakeholders will be monitoring the company's ability to translate this financial backing into sustainable, long-term growth while navigating the complex regulatory environment inherent to the medical laboratory industry.
See full Grove Labs company page
